The Eclipse Foundation has released the final version of GlassFish 8, an update of its enterprise Java application server. The new release serves as a compatible implementation of the Jakarta EE 11 ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Nov 12 (Reuters) - AI startup Parallel Web Systems, founded by former Twitter CEO Parag Agrawal, has raised $100 million to build web search infrastructure for artificial intelligence agents and fund ...
Arc Raiders has now sold over 4 million copies worldwide less than two weeks since its release date, cementing its commercial success. Publisher Nexon confirmed the milestone in a glowing press ...
JDK 25 brings powerful new features to Java and JVM developers. Here are seven new or updated features that could convince you to switch. Java continues its fast and feature-packed release schedule, ...
A developer leans back in frustration after another training run. A significant amount of work was spent over many months fine-tuning a large language model. Data pipelines were expanded, and compute ...
Abstract: The Java programming language, in its long-term support version 21 (released in September 2023), introduced Java virtual threads (prior to version 21, this was a prototype solution). While ...
Hosted on MSN
Minecraft Java vs Bedrock Parody
A parody comparing Minecraft Java Edition and Bedrock Edition with exaggerated gameplay moments and humorous edits. This video highlights the main differences in mechanics, visuals, and player ...
(Barcelona, Spain September 8, 2025, 10:45 a.m. CEST / UTC +2) — Treating patients who have stage III non-small cell lung cancer (NSCLC) with durvalumab concurrent with chemoradiotherapy (CRT) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results